In last trading session, Guardant Health Inc (NASDAQ:GH) saw 1.42 million shares changing hands with its beta currently measuring 0.86. Company’s recent per share price level of $17.56 trading at -$0.37 or -2.06% at ring of the bell on the day assigns it a market valuation of $2.14B. That closing price of GH’s stock is at a discount of -133.83% from its 52-week high price of $41.06 and is indicating a premium of 1.82% from its 52-week low price of $17.24. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.66 million shares which gives us an average trading volume of 1.63 million if we extend that period to 3-months.
Guardant Health Inc (NASDAQ:GH) trade information
Upright in the red during last session for losing -2.06%, in the last five days GH remained trading in the red while hitting it’s week-highest on Friday, 03/15/24 when the stock touched $17.56 price level, adding 5.34% to its value on the day. Guardant Health Inc’s shares saw a change of -35.08% in year-to-date performance and have moved -4.41% in past 5-day. Guardant Health Inc (NASDAQ:GH) showed a performance of -22.51% in past 30-days. Number of shares sold short was 7.05 million shares which calculate 3.73 days to cover the short interests.
Guardant Health Inc (GH) estimates and forecasts
Statistics highlight that Guardant Health Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -35.96% of value to its shares in past 6 months, showing an annual growth rate of 18.22% while that of industry is 12.10. Apart from that, the company came raising its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to increase by 35.40% in the current quarter and calculating -19.40% decrease in the next quarter. This year revenue growth is estimated to rise 17.70% from the last financial year’s standing.
18 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $150.42 million for the same. And 18 analysts are in estimates of company making revenue of $160.99 million in the next quarter that will end on Jun 2024. Company posted $128.71 million and $137.15 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 16.90% while estimating it to be 17.40% for the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -8.88% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 23.38% while estimates for its earnings growth in next 5 years are of 27.80%.
GH Dividends
Guardant Health Inc is more likely to be releasing its next quarterly report between May 07 and May 13 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Guardant Health Inc (NASDAQ:GH)’s Major holders
Insiders are in possession of 4.15% of company’s total shares while institution are holding 92.40 percent of that, with stock having share float percentage of 96.40%. Investors also watch the number of corporate investors in a company very closely, which is 92.40% institutions for Guardant Health Inc that are currently holding shares of the company. Vanguard Group Inc is the top institutional holder at GH for having 10.8 million shares of worth $386.76 million. And as of Jun 29, 2023, it was holding 9.18% of the company’s outstanding shares.
The second largest institutional holder is Blackrock Inc., which was holding about 9.68 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 8.22% of outstanding shares, having a total worth of $346.46 million.
On the other hand, Vanguard Total Stock Market Index Fund and Mutual Fund Ser Tr-Eventide Gilead Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 3.42 million shares of worth $122.31 million or 2.90% of the total outstanding shares. The later fund manager was in possession of 2.96 million shares on Jun 29, 2023, making its stake of worth around $106.06 million in the company or a holder of 2.52% of company’s stock.
